---
figid: PMC9110317__JZhejiangUnivSciB-23-5-423-g004
pmcid: PMC9110317
image_filename: JZhejiangUnivSciB-23-5-423-g004.jpg
figure_link: /pmc/articles/PMC9110317/figure/JZhejiangUnivSciB-23-5-423-g004/
number: Fig. 4
figure_title: 'Alleviation effect of hucMSC-Ex against LPS-induced FHC inflammation
  through lnc78583/HOXB13. (a) NTA analysis of hucMSC-Ex diameter. (b) Surface markers
  CD9, CD63, and HSP70 of hucMSC-Ex shown by western blot. (c) Electron microscope
  image of hucMSC-Ex. (d) CCK8 analysis illustrating the cell viability of FHC after
  treatment with or without hucMSC-Ex. (e) LDH release of FHC after treatment with
  or without hucMSC-Ex. (f‍‒‍h) qRT-PCR analyses of lnc78583, HOXB13, and IL-10 mRNA
  expression levels after treatment with or without hucMSC-Ex. (i) The protein expression
  levels of HOXB13, p-NF-κB, and NF-κB after treatment with or without hucMSC-Ex.
  (j, k) The gray values of HOXB13 and p-NF-κB protein expression related to NF-κB
  after treatment with or without hucMSC-Ex were analyzed by ImageJ software. Data
  are expressed as mean±standard error of the mean (SEM), n=11. * P<0.05, ** P<0.01,
  *** P<0.001. HucMSC-Ex: human umbilical cord mesenchymal stem cells-derived exosome;
  LPS: lipopolysaccharide; FHC: fetal human cell; HOXB13: homeobox B13; NTA: nanoparticle
  tracking analysis; CD: cluster of differentiation; HSP70: heat shock protein 70;
  CCK8: cell counting kit-8; LDH: lactic dehydrogenase; qRT-PCR: quantitative real
  time-polymerase chain reaction; IL-10: interleukin-10; mRNA: messenger RNA; p-NF-‍κB:
  phosphorylated nuclear factor-κB; NEG: negative group'
caption: 'Alleviation effect of hucMSC-Ex against LPS-induced FHC inflammation through
  lnc78583/HOXB13. (a) NTA analysis of hucMSC-Ex diameter. (b) Surface markers CD9,
  CD63, and HSP70 of hucMSC-Ex shown by western blot. (c) Electron microscope image
  of hucMSC-Ex. (d) CCK8 analysis illustrating the cell viability of FHC after treatment
  with or without hucMSC-Ex. (e) LDH release of FHC after treatment with or without
  hucMSC-Ex. (f‍‒‍h) qRT-PCR analyses of lnc78583, HOXB13, and IL-10 mRNA expression
  levels after treatment with or without hucMSC-Ex. (i) The protein expression levels
  of HOXB13, p-NF-κB, and NF-κB after treatment with or without hucMSC-Ex. (j, k)
  The gray values of HOXB13 and p-NF-κB protein expression related to NF-κB after
  treatment with or without hucMSC-Ex were analyzed by ImageJ software. Data are expressed
  as mean±standard error of the mean (SEM), n=11. * P<0.05, ** P<0.01, *** P<0.001.
  HucMSC-Ex: human umbilical cord mesenchymal stem cells-derived exosome; LPS: lipopolysaccharide;
  FHC: fetal human cell; HOXB13: homeobox B13; NTA: nanoparticle tracking analysis;
  CD: cluster of differentiation; HSP70: heat shock protein 70; CCK8: cell counting
  kit-8; LDH: lactic dehydrogenase; qRT-PCR: quantitative real time-polymerase chain
  reaction; IL-10: interleukin-10; mRNA: messenger RNA; p-NF-‍κB: phosphorylated nuclear
  factor-κB; NEG: negative group.'
article_title: HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated
  miR3202/HOXB13 pathway.
citation: Yuting XU, et al. J Zhejiang Univ Sci B. 2022 May 15;23(5):423-431.
year: '2022'

doi: 10.1631/jzus.B2100793
journal_title: Journal of Zhejiang University. Science. B
journal_nlm_ta: J Zhejiang Univ Sci B
publisher_name: Zhejiang University Press

keywords:
---
